USFE - ETF AI Analysis
Top Page
First Eagle US Equity ETF (USFE)
USFE’s rating suggests it is a solid, but not flawless, US equity ETF, supported by several high-quality companies. Strong contributors like Alphabet (GOOG), Oneok (OKE), and Newmont (NEM) help the fund with their robust financial performance, strategic investments, and generally positive outlooks, while holdings such as Becton Dickinson (BDX), Meta (META), and Workday (WDAY) introduce some caution due to valuation concerns and mixed technical signals. The main risk factor is that many top holdings share themes of high valuations and potential short-term volatility, which can make the fund more sensitive to market swings.
USFE vs. SPDR S&P 500 ETF (SPY)
- AUM
- 4.83M
- Region
- North America
- Expense Ratio
- 0.45%
- Beta
- 0.54
- Issuer
- First Eagle
- Inception Date
- Jan 27, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
USFE Summary
First Eagle US Equity ETF (USFE) is an actively managed fund that invests in a wide mix of U.S. companies of all sizes, with a focus on stocks the managers believe are trading for less than they’re really worth. It doesn’t track a set index, but instead follows a value-focused approach across many sectors, holding well-known names like Alphabet (Google) and Meta Platforms (Facebook). Someone might invest in USFE for broad U.S. stock market exposure with a value tilt and diversification across industries. A key risk is that its stock prices can rise and fall with the overall market and its value style can lag growth stocks for long periods.
How much will it cost me?
This ETF has an expense ratio of 0.45%, which means you’ll pay about $4.50 per year for every $1,000 you invest. That’s higher than the cost of many index (passively managed) ETFs, mainly because this fund is actively managed, with managers researching and selecting individual stocks.
What would affect this ETF?
USFE could benefit if the U.S. economy stays resilient, as its broad mix of sectors and value focus may help it find solid companies that are temporarily out of favor, especially in areas like health care, communication services, and technology where leaders such as Alphabet and Meta could gain from ongoing digital and medical trends. On the other hand, rising interest rates, tighter regulations on big tech or financial firms, or a downturn that hits value stocks or U.S. markets in general could weigh on the fund’s performance despite its diversification.
USFE Top 10 Holdings
USFE leans heavily on big U.S. names, with tech and communication giants like Meta and Alphabet doing much of the heavy lifting as their shares keep rising on AI and digital advertising momentum. Health care is another key pillar: Elevance and HCA are mostly steady, helping smooth out bumps but not exactly turbocharging returns. Energy player Oneok and financial stalwart BNY Mellon are quietly boosting results, while software names like Salesforce, Oracle, and Workday are losing steam and dragging on performance. Overall, it’s a U.S.-centric, value‑tilted mix with notable exposure to large, established franchises.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Becton Dickinson | 5.18% | $250.31K | $53.90B | 10.31% | 67Neutral | |
| Oneok | 4.69% | $226.33K | $61.20B | 45.49% | 82Outperform | |
| Alphabet Class C | 3.77% | $182.10K | $3.41T | -1.31% | 82Outperform | |
| Meta Platforms | 4.09% | $197.35K | $1.57T | -7.72% | 76Outperform | |
| Elevance Health | 3.75% | $181.05K | $90.76B | 30.48% | 76Outperform | |
| HCA Healthcare | 3.76% | $181.67K | $98.85B | 1.37% | 70Neutral | |
| Salesforce | 3.11% | $150.32K | $188.61B | -10.71% | 80Outperform | |
| Workday | 2.89% | $139.75K | $47.67B | -15.05% | 73Outperform | |
| Bank of New York Mellon | 2.94% | $141.90K | $99.81B | 36.31% | 75Outperform | |
| Oracle | 2.71% | $130.63K | $395.11B | -49.13% | 66Neutral |
USFE Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For USFE, the sentiment is Neutral. The current price of 37.03 is above the 20-day moving average (MA) of 36.86, below the 50-day MA of 37.09, and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.12 indicates Negative momentum. The RSI at 51.89 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for USFE.
USFE Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $37.03 | $41.00(10.72% Upside) | $4.83M | 0.45% | 70Outperform | |
| $37.32 | $42.64(14.25% Upside) | $93.14M | 0.85% | 68Neutral | |
| $31.63 | $37.50(18.56% Upside) | $90.20M | 0.75% | 70Neutral | |
| $23.69 | $29.76(25.66% Upside) | $77.53M | 0.75% | 68Neutral | |
| $32.26 | $34.94(8.30% Upside) | $47.32M | 0.87% | 58Neutral | |
| $48.30 | $56.65(17.30% Upside) | $40.82M | 0.45% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| USFE | First Eagle US Equity ETF | 37.03 | 2.15 | 6.15% | |
| STNC | Stance Equity ESG Large Cap Core ETF | 37.32 | 5.00 | 15.49% | |
| SOVF | Sovereign's Capital Flourish Fund | 31.63 | 3.21 | 11.29% | |
| SASS | M.D. Sass Concentrated Value ETF | 23.69 | -1.43 | -5.68% | |
| CVAR | Cultivar ETF | 32.26 | 4.92 | 17.98% | |
| GVLE | Goldman Sachs Value Opportunities ETF | 48.30 | 9.20 | 23.52% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.